11 January 2016 -  Mylan today confirmed that it submitted its abbreviated new drug application for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder to the U.S. FDA in December 2015.

For more details, go to: http://newsroom.mylan.com/2016-01-11-Mylan-Confirms-FDA-Submission-of-ANDA-for-Generic-Advair-Diskus